drugset / Trial / NCT00673465

Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)

NCT00673465 ↗

Phase 1 Completed 17 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effect of SCH 497079 on metabolic parameters and to determine the influence of race/ethnic origin on therapeutic response.

Timeline

Start
2008-04-17
Primary completion
2008-12-11
Completion
2008-12-11

Outcome

Missed primary endpoint

registry analysis (superiority or other test); SCH 497079 vs Placebo; p = 0.5269; Difference in least squares mean -4.40 (95% CI -18.5 to 9.7); ANOVA NCT00673465 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1500 mg Oral
Subject SCH 497079 Unknown 100 mg Oral